Biocept, Inc

www.biocept.com

Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both in Circulating Tumor Cells (CTCs) and in plasma (cell free circulating tumor DNA).

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

NEW RESEARCH FROM THE CARIS PRECISION ONCOLOGY ALLIANCE FINDS PROGNOSTIC AND PREDICTIVE DRUG-INDUCED GENE SIGNATURES FOR COLORECTAL CANCER PATIENTS

Caris Life Sciences | April 11, 2022

news image

Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, to present findings that provide a deeper understanding that tumor expression of genes related to extent of drug exposure, stratified by p53 status, is associated with clinical outcomes on the common chemotherapeutic regimens used to treat metastatic colorectal cancer (CRC). These results will be presented at the 2022 American ...

Read More

Industry Outlook

SARTORIUS STEDIM BIOTECH ACQUIRES U.S.-BASED PURIFICATION EXPERT WATERSEP BIOSEPARATIONS LLC

Sartorius Stedim Biotech | December 10, 2020

news image

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical business, today procured U.S.- based filtration master WaterSep BioSeparations LLC. WaterSep BioSeparations develops, makes and markets empty fiber layer gadgets and pre-cleaned congregations for upstream and downstream biopharmaceutical applications. The exclusive organization situated in Marlborough, Massachusetts, USA, employs around 15 individuals and is required to procure income of approximately 2.5 million ...

Read More

Medical

DOVER TO ACQUIRE MANUFACTURER OF FLOW-MEASUREMENT DEVICES FOR BIOPHARMA AND SEMICONDUCTOR PRODUCTION APPLICATIONS

Dover | May 11, 2022

news image

Dover (NYSE: DOV) announced today that it has entered into a definitive agreement to acquire Malema Engineering Corporation ("Malema"), a designer and manufacturer of high-precision, mission-critical flow-measurement and control instruments serving customers in the biopharmaceutical, semiconductor, and industrial sectors. Malema will become part of the PSG business unit within Dover's Pumps & Process Solutions segment. Malema's products will expand Dover'...

Read More

Medical

MATICA BIO LAUNCHES MATIMAX™ CELL LINES AT BIO INTERNATIONAL CONVENTION

Businesswire | June 07, 2023

news image

Matica Biotechnology, Inc. a contract development and manufacturing organization specializing in the GMP production of cell and gene therapies, today unveiled the company’s new MatiMax™ cell lines at the BIO International Convention, taking place in Boston, MA.. Proprietary to Matica Bio, MatiMaxTM HEK293 and HEK293T cell lines have been rigorously optimized to enable. Faster doubling times – Reaching as low as 17 hours, which can significan...

Read More
news image

Cell and Gene Therapy

NEW RESEARCH FROM THE CARIS PRECISION ONCOLOGY ALLIANCE FINDS PROGNOSTIC AND PREDICTIVE DRUG-INDUCED GENE SIGNATURES FOR COLORECTAL CANCER PATIENTS

Caris Life Sciences | April 11, 2022

Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, to present findings that provide a deeper understanding that tumor expression of genes related to extent of drug exposure, stratified by p53 status, is associated with clinical outcomes on the common chemotherapeutic regimens used to treat metastatic colorectal cancer (CRC). These results will be presented at the 2022 American ...

Read More
news image

Industry Outlook

SARTORIUS STEDIM BIOTECH ACQUIRES U.S.-BASED PURIFICATION EXPERT WATERSEP BIOSEPARATIONS LLC

Sartorius Stedim Biotech | December 10, 2020

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical business, today procured U.S.- based filtration master WaterSep BioSeparations LLC. WaterSep BioSeparations develops, makes and markets empty fiber layer gadgets and pre-cleaned congregations for upstream and downstream biopharmaceutical applications. The exclusive organization situated in Marlborough, Massachusetts, USA, employs around 15 individuals and is required to procure income of approximately 2.5 million ...

Read More
news image

Medical

DOVER TO ACQUIRE MANUFACTURER OF FLOW-MEASUREMENT DEVICES FOR BIOPHARMA AND SEMICONDUCTOR PRODUCTION APPLICATIONS

Dover | May 11, 2022

Dover (NYSE: DOV) announced today that it has entered into a definitive agreement to acquire Malema Engineering Corporation ("Malema"), a designer and manufacturer of high-precision, mission-critical flow-measurement and control instruments serving customers in the biopharmaceutical, semiconductor, and industrial sectors. Malema will become part of the PSG business unit within Dover's Pumps & Process Solutions segment. Malema's products will expand Dover'...

Read More
news image

Medical

MATICA BIO LAUNCHES MATIMAX™ CELL LINES AT BIO INTERNATIONAL CONVENTION

Businesswire | June 07, 2023

Matica Biotechnology, Inc. a contract development and manufacturing organization specializing in the GMP production of cell and gene therapies, today unveiled the company’s new MatiMax™ cell lines at the BIO International Convention, taking place in Boston, MA.. Proprietary to Matica Bio, MatiMaxTM HEK293 and HEK293T cell lines have been rigorously optimized to enable. Faster doubling times – Reaching as low as 17 hours, which can significan...

Read More

Resources

resource image

Cell and Gene Therapy

VIA Thaw™ automated dry thawer

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us